Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma
We designed multimodal tumor vaccine that consists of irradiated tumor cells infected with the oncolytic IL-12-expressing HSV-1 virus, M002. This vaccine was tested against the syngeneic neuroblastoma mouse model Neuro 2a injected into the right caudate nucleus of the immunocompetent A/J mice. Mice...
Saved in:
| Main Authors: | David F. Bauer, Larisa Pereboeva, G. Yancey Gillespie, Gretchen A. Cloud, Osama Elzafarany, Catherine Langford, James M. Markert, Lawrence S. Lamb Jr. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2016/2568125 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antitumor power of oncolytic HSV engineered with IL-12 and IL-15
by: Lei Zhang, et al.
Published: (2025-09-01) -
Germ cell depletion using HSV-TK in mouse testes
by: Constance Dollet, et al.
Published: (2025-03-01) -
HSV-1 alters lipid metabolism and induces lipid droplet accumulation in functionally impaired mouse dendritic cells
by: Mónica A. Farías, et al.
Published: (2025-05-01) -
Anti-HSV-1 agents: an update
by: Wenwen Lv, et al.
Published: (2025-01-01) -
Should Systematic HSV Serological Screening of Donors Be Implemented to Manage Mismatched HSV D+/R− Liver Transplants?
by: J. Besombes, et al.
Published: (2025-07-01)